Cn /En

News Center

——

Company news

Industry news

InnoModels Biotechnology: ADCC Platform Features

Author:

InnoModels

Release time:

2024-04-18

With the continuous progress of science and technology, mankind's understanding of life sciences is deepening. In this process, by virtue of its excellent R&D strength and innovation ability, InnoModels Biotechnology has successfully built an ADCC (Antibody Dependent Cytotoxicity) in vitro killing experimental platform, which opens up a new path for the research and development of tumor immunotherapy.
InnoModels' ADCC platform leads the development of tumor immunotherapy field with its unique advantages. Firstly, the platform adopts humanized mouse model (HIS) and humanized tumor xenograft platform (PDX), which makes the experimental data closer to the clinical reality, and provides a more accurate and reliable basis for the development of new drugs. Secondly, by utilizing the key players of natural immune response such as NK cells, the ADCC platform is able to efficiently attack tumor cells labeled by antibodies, providing strong support for tumor immunotherapy.

In the field of tumor immunotherapy, InnoModels' ADCC platform not only has a wide range of application prospects, but also has high practical value. On the one hand, through the platform, researchers can conduct in-depth studies on different types of tumor cells, further revealing the mechanisms of tumor development and progression, and providing scientific basis for early diagnosis, treatment and prevention of tumors. On the other hand, the ADCC platform can also provide powerful support for the development of new drugs, helping researchers screen out drugs with efficient anti-tumor activity and provide patients with safer and more effective treatment options.
It is worth mentioning that InnoModels Biotechnology always adheres to a patient-centered approach and is committed to providing individualized medical solutions for patients. Through the ADCC platform, doctors can formulate more precise and personalized treatment plans for patients' specific conditions, improving treatment effects and reducing treatment costs, so that patients can truly benefit.
In conclusion, with its unique advantages and application value, InnoModels' ADCC platform is leading the development of the tumor immunotherapy field. In this era full of challenges and opportunities, InnoModels Biotechnology will continue to uphold the spirit of innovation and pragmatism, and make greater contributions to the cause of human health.

InnoModels Biotechnology: What are the characteristics of T-cell-mediated killing experimental platform?

InnoModels Biotechnology CDC In Vitro Immuno-Tumor Cell Co-Culture Killing Experimental Platform

InnoModels Biotechnology: What are the characteristics of T-cell-mediated killing experimental platform?

InnoModels Biotechnology CDC In Vitro Immuno-Tumor Cell Co-Culture Killing Experimental Platform

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License